Medical Crossfire®: New Horizons in Acute Lymphoblastic Leukemia—How The Experts Apply New Evidence from AYA to Adult Scenarios

Program Overview and ARS Demographic and Pre-Assessment Questions

How to integrate molecular genetics, MRD and therapeutic drug monitoring to customize treatment for pediatric ALL